Clinical Trials Sponsored by Netherlands Institute for Innovative Ocular Surgery

Total 93 results

Vienna Institute for Research in Ocular Surgery

Completed

Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap Technique

Macular Holes

Austria
Vienna Institute for Research in Ocular Surgery

Unknown

Epithelial Thickness Map

Keratoconus

Austria
Vienna Institute for Research in Ocular Surgery

Completed

Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling

Macular Edema, Cystoid

Austria
Vienna Institute for Research in Ocular Surgery

Completed

Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling

Epiretinal Membrane

Austria
Vienna Institute for Research in Ocular Surgery

Completed

Reconstruction of Pathological Changes of the Ophthalmic Artery in Patients With Retinal Artery Occlusion

Retinal Artery Occlusion

Austria
Vienna Institute for Research in Ocular Surgery

Unknown

Prevention of UV- Induced Apoptosis by Caffeine (Caff2)

Cataract

Austria
Vienna Institute for Research in Ocular Surgery

Unknown

MP3 (Microperimeter 3) Reproducibility in Healthy Subjects and Macular Patients

Macular Degeneration

Austria
Medical University of Graz
Vienna Institute for Research in Ocular Surgery

Completed

Characteristics and Risk Ratios of Late Intraocular Lens (IOL) Complication

Complications
Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Intense Pulsed Light in Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Repeatability in Measurements of Two ssOCT and One OLCR Biometer

Cataract Senile

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

LEC Proliferation in Vivo and In-vitro

Posterior Capsule Opacification

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Computer-based Tutorial for the Informed Consent Process for Cataract Surgery in Turkish or Serbian Speaking Patients

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of a New EDOF-IOL With a Standard-EDOF-IOL

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Reading Quality in Three Different Patient Groups

Pseudophakia

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of Stellaris Standard Infusion With Stellaris Elite

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparing an Intraoperative vs. a Standard Wavefront Device

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

High Resolution Immersion Ultrasound for iIOL Power Calculation

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Impact of a Corneal Pre-cut on Wound Architecture and Astigmatism in Cataract Surgery - a Pilot Study

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Rotation Stability of Toric Intraocularlens (IOL) Compared Sitting Against Lying After Cataract Operation

Astigmatism

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Withdrawn

Performance of a Hydrophilic and a Hydrophobic Intraocular Lens of Similar Design

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Diurnal Changes of the Cornea - a Pilot Study

Astigmatism

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Perioperative Stress and Pain Perception of Second Eye Cataract Surgery

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Protecting the Corneal Endothelium During Cataract Surgery Using the Anterior Capsule

Endothelial Cell Loss, Corneal
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Prediction of Pseudophakodonesis of Intraocular Lenses

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Morphologic Changes After Membrane Peeling With Air Tamponade and Balanced Salt Solution

Epiretinal Membrane | Macular Pucker

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Intraocular Lens Power Calculation Using Pre- and Intra-operative Measurements

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy

Central Serous Chorioretinopathy

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Intra-operative Measurements to Predict the Position of the Intraocular Lens Post-operatively

Cataracts
Prim. Prof. Dr. Oliver Findl, MBA

Recruiting

Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections

Age-related Macular Degeneration | Diabetic Macular Edema | Retinal Vein Occlusion

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of Wide-field Retinal Imaging

Retinal Disease

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Posterior Capsule Opacification After Lens Capsule Polishing

Posterior Capsule Opacification

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Assessing the Astigmatism Reducing Effect With Toric IOLs in Eyeswith Low Astigmatism (Low Asti)

Cataract | Astigmatism

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Anterior Chamber Depth Variability Between Two Lenses With Different Materials

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Reading Analysis in Ophthalmologic Patients

Glaucoma | Age Related Macular Degeneration | Epiretinal Membrane | Diabetic Maculopathy

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Comparison of 2 Diffractive Trifocal IOLs

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Unknown

Low-add Multifocal vs. Monofocal IOLs

Cataract

Austria
Prim. Prof. Dr. Oliver Findl, MBA

Completed

Performance of a Single-piece Toric Acrylic Intraocular Lens

Cataract | Corneal Astigmatism
Prim. Prof. Dr. Oliver Findl, MBA
ESCRS

Unknown

Influence of Posterior Vitreous Detachment on Retinal Detachment After Lens Surgery in Myopic Eyes (MYOPRED)

Cataract | Myopia | Pseudophakic Retinal Detachment

Austria
University Hospital, Ghent
GlaxoSmithKline; Novartis Vaccines; University of Surrey; Innovative Medicines... and other collaborators

Completed

Placebo Controlled Study to Generate Data Characterising Clinical Events, Physiological Responses and Immune Responses

Safety Markers of Adjuvanted Influenza Vaccine

Belgium
University Hospital, Ghent
GlaxoSmithKline; Sanofi Pasteur, a Sanofi Company; Novartis Vaccines; University... and other collaborators

Completed

Placebo Controlled Study to Generate Data Characterising Safety Parameters and Immune Responses

Prevention of Infections With Bordetella Pertussis

Belgium
Foundation for Innovative New Diagnostics, Switzerland
London School of Hygiene and Tropical Medicine; Leishmaniasis Research and... and other collaborators

Recruiting

Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure (VL-ToC)

Visceral Leishmaniasis

Ethiopia
University of Leeds
GlaxoSmithKline; AstraZeneca; Sanofi Pasteur, a Sanofi Company; BioMérieux; Da Volterra and other collaborators

Completed

COMBACTE-CDI Understanding the Burden of C. Difficile Infection (COMBACTE-CDI)

Clostridium Difficile Infection

United Kingdom
Foundation for Innovative New Diagnostics, Switzerland
Swiss Tropical & Public Health Institute; University of Cape Town; The HIV Netherlands... and other collaborators

Completed

FujiLAM Prospective Evaluation Trial

Diagnosis of Tuberculosis in People Living With HIV

Malawi, South Africa, Tanzania, Thailand, Uganda, Vietnam, Zambia

Clinical Trials Sponsored by Netherlands Institute for Innovative Ocular Surgery

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations